Posterior fossa meningiomas: perioperative predictors of extent of resection, overall survival and progression-free survival

被引:0
|
作者
Marco V. Corniola
Jean-Michel Lemée
Michele Da Broi
Holger Joswig
Karl Schaller
Eirik Helseth
Torstein R. Meling
机构
[1] Geneva University Hospitals,Department of Clinical Neurosciences, Division of Neurosurgery
[2] University of Oslo,Faculty of Medicine
[3] University of Geneva,Faculty of Medicine
[4] Oslo University Hospital,Department of Neurosurgery
来源
Acta Neurochirurgica | 2019年 / 161卷
关键词
Posterior Fossa; Meningioma; Overall survival; Progression-free survival;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1003 / 1011
页数:8
相关论文
共 50 条
  • [31] Improved estimation of overall survival and progression-free survival for state transition modeling
    Wigfield, Peter C.
    Heeg, Bart
    Ouwens, Mario
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (01)
  • [32] Correlation of progression-free and post-progression survival with overall survival in advanced colorectal cancer
    Petrelli, F.
    Barni, S.
    ANNALS OF ONCOLOGY, 2013, 24 (01) : 186 - 192
  • [33] Progression-free survival versus post-progression survival and overall survival in WHO grade 2 gliomas
    Sagberg, Lisa Millgard
    Salvesen, Oyvind
    Jakola, Asgeir Store
    Thurin, Erik
    de Dios, Eddie
    Nawabi, Noah L. A.
    Kilgallon, John L.
    Bernstock, Joshua D.
    Kavouridis, Vasileios K.
    Smith, Timothy R.
    Solheim, Ole
    ACTA ONCOLOGICA, 2024, 63 : 798 - 804
  • [34] Examining extent of resection and progression-free survival in glioblastoma: A systematic review and meta-analysis.
    Brown, Timothy J.
    Brennan, Matt Christopher
    Li, Yan Michael
    Church, Ephraim W.
    Brandmeir, Nicholas J.
    Rakszawski, Kevin
    Patel, Akshal S.
    Rizk, Elias B.
    Suki, Dima
    Sawaya, Raymond
    Glantz, Michael J.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [35] Radiographic Progression-Free Survival and Clinical Progression-Free Survival as Potential Surrogates for Overall Survival in Men With Metastatic Hormone-Sensitive Prostate Cancer
    Halabi, Susan
    Roy, Akash
    Rydzewska, Larysa
    Guo, Siyuan
    Godolphin, Peter
    Hussain, Maha
    Tangen, Catherine
    Thompson, Ian
    Xie, Wanling
    Carducci, Michael A.
    Smith, Matthew R.
    Morris, Michael J.
    Gravis, Gwenaelle
    Dearnaley, David P.
    Verhagen, Paul
    Goto, Takayuki
    James, Nick
    Buyse, Marc E.
    Tierney, Jayne F.
    Sweeney, Christopher
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (09)
  • [36] IS PROGRESSION-FREE SURVIVAL A GOOD INDICATOR OF OVERALL SURVIVAL FOR PAZOPANIB IN PATIENTS WITH SYNOVIAL SARCOMA?
    Han, J.
    Lee, S.
    Cho, E.
    VALUE IN HEALTH, 2022, 25 (12) : S489 - S490
  • [37] Progression-free survival, overall survival and quality of life: What is their medicoeconomic importance in oncology?
    Pavlovic, Mira
    Garnier, Jerome
    Durand-Zaleski, Isabelle
    Bilbault, Pascal
    Gaudin, Anne-Francoise
    Le Jeunne, Claire
    Lalaude, Olivier
    Roze, Stephane
    De Sahb, Rima
    Sapede, Claudine
    THERAPIE, 2016, 71 (01): : 59 - 67
  • [38] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Belin, Lisa
    Tan, Aidan
    De Rycke, Yann
    Dechartres, Agnes
    BRITISH JOURNAL OF CANCER, 2020, 122 (11) : 1707 - 1714
  • [39] Combining progression-free survival and overall survival as a novel composite endpoint for glioblastoma trials
    Trippa, Lorenzo
    Wen, Patrick Y.
    Parmigiani, Giovanni
    Berry, Donald A.
    Alexander, Brian M.
    NEURO-ONCOLOGY, 2015, 17 (08) : 1106 - 1113
  • [40] THE ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ONCOLOGY TRIALS: A SIMULATION EXERCISE
    Wu, D. B. C.
    Manjula, I. S.
    Yu, D.
    VALUE IN HEALTH, 2022, 25 (01) : S198 - S198